BlackRock’s Biomerica BMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.8K | Hold |
18,636
| – | – | ﹤0.01% | 5275 |
|
|
2026
Q1 | $39.5K | Hold |
18,636
| – | – | ﹤0.01% | 5181 |
|
|
2025
Q4 | $47K | Hold |
18,636
| – | – | ﹤0.01% | 5069 |
|
|
2025
Q3 | $52.7K | Hold |
18,636
| – | – | ﹤0.01% | 4973 |
|
|
2025
Q2 | $58.9K | Buy |
18,636
+1
| +0% | +$4 | ﹤0.01% | 4959 |
|
|
2025
Q1 | $84.5K | Hold |
18,635
| – | – | ﹤0.01% | 4811 |
|
|
2024
Q4 | $44.7K | Hold |
18,635
| – | – | ﹤0.01% | 4974 |
|
|
2024
Q3 | $48.8K | Hold |
18,635
| – | – | ﹤0.01% | 4819 |
|
|
2024
Q2 | $65.6K | Hold |
18,635
| – | – | ﹤0.01% | 4801 |
|
|
2024
Q1 | $124K | Sell |
18,635
-78
| -0.4% | -$634 | ﹤0.01% | 4684 |
|
|
2023
Q4 | $187K | Sell |
18,713
-58
| -0.3% | -$439 | ﹤0.01% | 4659 |
|
|
2023
Q3 | $129K | Sell |
18,771
-1,011
| -5% | -$10K | ﹤0.01% | 4784 |
|
|
2023
Q2 | $215K | Sell |
19,782
-3,006
| -13% | -$35.6K | ﹤0.01% | 4714 |
|
|
2023
Q1 | $341K | Buy |
22,788
+47
| +0.2% | +$1.01K | ﹤0.01% | 4637 |
|
|
2022
Q4 | $609K | Sell |
22,741
-178
| -0.8% | -$5.11K | ﹤0.01% | 4559 |
|
|
2022
Q3 | $720K | Sell |
22,919
-124
| -0.5% | -$3.21K | ﹤0.01% | 4601 |
|
|
2022
Q2 | $533K | Buy |
23,043
+52
| +0.2% | +$1.49K | ﹤0.01% | 4759 |
|
|
2022
Q1 | $821K | Buy |
22,991
+177
| +0.8% | +$5.88K | ﹤0.01% | 4726 |
|
|
2021
Q4 | $709K | Buy |
22,814
+1,337
| +6% | +$51.5K | ﹤0.01% | 4768 |
|
|
2021
Q3 | $774K | Buy |
21,477
+1,762
| +9% | +$57.9K | ﹤0.01% | 4631 |
|
|
2021
Q2 | $633K | Sell |
19,715
-7,830
| -28% | -$265K | ﹤0.01% | 4633 |
|
|
2021
Q1 | $1.2M | Buy |
27,545
+1,291
| +5% | +$66.2K | ﹤0.01% | 4450 |
|
|
2020
Q4 | $1.05M | Buy |
26,254
+397
| +2% | +$19.9K | ﹤0.01% | 4204 |
|
|
2020
Q3 | $1.43M | Sell |
25,857
-106
| -0.4% | -$6.85K | ﹤0.01% | 3996 |
|
|
2020
Q2 | $1.51M | Buy |
25,963
+25,158
| +3,125% | +$1.41M | ﹤0.01% | 3912 |
|
|
2020
Q1 | $46K | Buy |
805
+71
| +10% | +$2.17K | ﹤0.01% | 4489 |
|
|
2019
Q4 | $18K | Buy |
+734
| New | +$17.6K | ﹤0.01% | 4674 |
|
|
2019
Q3 | – | Sell |
-639
| Closed | -$14K | – | 4975 |
|
|
2019
Q2 | $14K | Sell |
639
-1,598
| -71% | -$30.7K | ﹤0.01% | 4725 |
|
|
2019
Q1 | $45K | Sell |
2,237
-154
| -6% | -$3K | ﹤0.01% | 4492 |
|
|
2018
Q4 | $33K | Sell |
2,391
-44
| -2% | -$989 | ﹤0.01% | 4526 |
|
|
2018
Q3 | $70K | Buy |
2,435
+99
| +4% | +$2.97K | ﹤0.01% | 4505 |
|
|
2018
Q2 | $72K | Buy |
+2,336
| New | +$70.9K | ﹤0.01% | 4511 |
|
Other funds holding BMRA
VCM
VFT
NA
TRCT
HCM
HI
IA
BlackRock's BMRA Position: Q2 2026 in Review
BlackRock held its Biomerica (BMRA) position steady in Q2 2026 at 18,636 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5275.
BlackRock first reported a position in BMRA in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.51M in Q2 2020. 15 funds tracked by Wall St. Rank hold BMRA as of Q2 2026.
- BlackRock held 18,636 shares of Biomerica worth $32.8K as of Q2 2026.
- BlackRock left its Biomerica share count unchanged in Q2 2026.
- Biomerica made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5275 holding.
- BlackRock first reported a position in Biomerica in Q2 2018 and has held it in 32 quarters since.
- BlackRock's Biomerica position peaked at $1.51M in Q2 2020.
- 15 funds tracked by Wall St. Rank held Biomerica as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.